The DIRECT-MT trial is a Multicenter randomized clinical Trial investigating the effect of direct intra-arterial thrombectomy compared with IV alteplase followed by intra-arterial thrombectomy, on functional outcome in patients with acute ischemic stroke, caused by an anterior circulation large vessel occlusion that is confirmed by neuro-imaging.
DIRECT-MT is one of the randomized clinical trials that will be conducted by National Health and Family Planning Commission of the People's Republic of China (ClinicalTrials.gov Identifier:
NCT03469206 ) . The trial will be executed in collaboration with MRCLEAN NO-IV investigators.
The upper menu helps you to navigate through this website and access more information about this trial.
Kind regards
On behalf of the DIRECT-MT executive committee
DIRECT-MT principle investigators